Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.6B | 1.5B | 1.4B | 1.4B |
| Cost of revenue | 612M | 585M | 570M | 551M |
| Gross profit | 942M | 925M | 817M | 832M |
| Operating expense | ||||
| Research & development | 88M | 79M | 86M | 84M |
| Selling general and admin | 630M | 603M | 584M | 570M |
| Other operating expenses | — | — | — | — |
| Operating income | 224M | 243M | 147M | 178M |
| Non operating interest income | ||||
| Income | 4M | 4M | 6M | 3M |
| Expense | 20M | 10M | 0 | 7M |
| Other income expense | — | — | — | — |
| Pretax income | 208M | 237M | -181M | 174M |
| Tax provision | 20M | 54M | -46M | 40M |
| Net income | 188M | 183M | -135M | 134M |
| Basic EPS | 0.7 | 0.7 | -0.5 | 0.5 |
| Diluted EPS | 0.7 | 0.7 | -0.5 | 0.5 |
| Basic average shares | 264.8M | 269.1M | 264.7M | 268M |
| Diluted average shares | 264.8M | 269.1M | 264.7M | 268M |
| EBITDA | 322M | 335M | 241M | 270M |
| Net income from continuing op. | 188M | 183M | -135M | 134M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |